Growth & Sustainability

We are passionate about our role and responsibility to help protect our planet. We strive to look beyond medicines and consider the interconnections of climate, society, nature and health to deliver real impact to society.
Across the EMEA region, we are focused on practical actions that reduce our environmental impact while supporting sustainable growth. Our priority areas include transitioning our company car schemes towards electric and hybrid vehicles, reducing emissions from business travel through more informed decision-making and improving the efficiency of energy use across our offices.

We are also advancing our work on the sustainable patient pathway, considering how the delivery of our medicines can minimise environmental impact while maintaining high standards of patient care.

At a global level, Kyowa Kirin remains committed to the United Nations Sustainable Development Goals and to the Kirin Group’s Environmental Vision 2050, including a target to reduce CO₂ emissions by 55% by 2030 compared to 2019. We have already reported a reduction in Scope 1 and Scope 2 emissions in 2025 of 70% compared to our 2019 baseline, reflecting continued progress in areas such as renewable energy sourcing and operational efficiency.

Building on this progress, we continue to develop and implement targeted decarbonisation initiatives across our operations. These efforts are supported by improved data, governance and collaboration across our business, enabling us to embed sustainability into our decision-making and deliver long-term value for patients, society and the environment.